GgoogleSE first seen 9 h ago, last 5 h ago, peak #5
Novo Nordisk cuts Wegovy price in Sweden by 20%
Original: wegovy
Novo Nordisk is lowering the price of its weight-loss drug Wegovy by 20 percent in Sweden, according to multiple Swedish business and news outlets. The move comes as GLP-1 medicines, once marketed primarily as obesity treatments for patients, are increasingly described in industry coverage as lifestyle drugs competing for customers, intensifying pressure on pricing.
Why now: Novo Nordisk's 20% price cut on Wegovy in Sweden signals intensifying competition and market pressure in the weight-loss drug sector
Rank over time, top of the chart is #1. 3 snapshots from 5 h ago to 5 h ago.
Evidence
- Novo sänker priset på Wegovy® med 20 procent · Mynewsdesk
- Novo sänker priset på viktläkemedel · Omni – Alla nyheter. Alla perspektiv.
- Once described as obesity medicines for 'patients,' GLP-1s are increasingly lifestyle drugs for 'customers' · STAT
- Novo kapar priset på Wegovy i Sverige · EFN
- Peptide Ruling Stalls | PharmExec · Pharmaceutical Executive
API: https://socialmediatrends-api.osmike.com/v1/trends/580306